 |
|
|
AnalytiCon applies a flexible modular target-to-lead drug discovery process, composed of tailor-made biology and pharmacology building blocks which can be selected, modified, and aligned by our customers in the most efficient and productive way. AnalytiCon has built drug discovery skills and expertise in therapeutic areas such as cancer, infection, inflammatory and metabolic diseases. A typical generic flow scheme of our Modular Drug Discovery Process (MDDP) is shown in Fig 1.
Fig.1 Typical Modular Drug Discovery Process (flow scheme) performed by AnalytiCon.